Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013
June 19, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 19, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Awarded Second U.S. Patent for Abuse Resistant Drug Formulation
April 23, 2013 08:23 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 23, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the issuance of U.S. Patent No. 8,425,933 entitled...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC
April 22, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 22, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a $10 million common stock purchase...
Avid Bioservices to Highlight Recent Successes in Reducing Manufacturing Costs and Novel Ways of Controlling Critical Process Parameters That Lead to Consistent Product Quality at IBC'S Biopharmaceutical Development and Production Conference
February 26, 2013 15:20 ET | Avid Bioservices
TUSTIN, CA and HUNTINGTON BEACH, CA--(Marketwire - Feb 26, 2013) - Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), today announced that it will present two...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal 2013
February 14, 2013 16:20 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
February 06, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that on January 31, 2012, the U.S. Food and Drug Administration approved the...
PCI Sponsors Second Annual Massachusetts CRO/CMO Symposium
February 04, 2013 11:59 ET | PCI Synthesis
NEWBURYPORT, MA--(Marketwire - Feb 4, 2013) - PCI (www.pcisynthesis.com), a 13-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Announces First Shipments From Expanded 15,000 Square Foot Facility
January 28, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 28, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced that Elite is now using and shipping packaged product from its...
Avid Bioservices Announces Completion of Facility Upgrades in Response to Increased Demand for Its Contract Manufacturing Services
December 13, 2012 11:00 ET | Avid Bioservices
TUSTIN, CA--(Marketwire - Dec 13, 2012) - Avid Bioservices, Inc, a contract manufacturing organization (CMO) focused on the process development and manufacturing of monoclonal antibodies, proteins...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces First Shipment of Generic Phendimetrazine Tablet Product
November 15, 2012 07:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today the initial shipment of Phendimetrazine tartrate 35 mg tablets, the generic...